Ara
Toplam kayıt 48, listelenen: 31-40
Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma
(SAGE Publications Ltd, 2022)
Sarcomas probably develop after malignant transformation of embryonic mesenchymal cells and have broad spectrum histopathologically since they can develop from striated skeletal muscle and smooth muscle, fat and fibrous ...
Bilateral Petrous Apex Cephalocele Associated with a Wide Sella
(Wolters Kluwer, 2021)
Petrous apex cephalocele (PAC) is a rare type of cephalocele. It is usually asymptomatic. It can be unilateral or bilateral. Bilateral cases are less common. They are etiologically and clinically different entities from ...
Aortic dissection type 1, windsock sign, neglected lead, and Kounis syndrome: What a coincidence! Reply
(TURKISH SOC CARDIOLOGY, 2021)
Letter to Editor
Axolotl: A resourceful vertebrate model for regeneration and beyond
(WILEY, 2022)
The regenerative capacity varies significantly among the animal kingdom. Successful regeneration program in some animals results in the functional restoration of tissues and lost structures. Among the highly regenerative ...
Do blood eosinophil levels affect the prognosis of AECOPD patients?
(NLM (Medline), 2022)
Letter to editor
Obesity and the Mother Goddess of Neolithic Çatalhöyük
(Springer Science and Business Media Deutschland GmbH, 2023)
Letter to Editor
Importance of nutritional assessment in evaluating patients with chemotherapy-induced febrile neutropenia: Insights from Heo et al.'s study and future implications
(W B SAUNDERS CO-ELSEVIER INC, 2023)
Letter to editor
Butyrylcholinesterase in lipid metabolism: A new outlook
(WILEY, 2023)
Cholinesterase enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are traditionally associated with the termination of acetylcholine mediated neural signaling. The fact that these ubiquitous enzymes are ...
Fournier's Gangrene: Importance of Screening for Malnutrition and Sarcopenia on Admission
(SAGE PUBLICATIONS INC, 2023)
Letter to editor